Previous studies have indicated Cadherin 4 (CDH4) was significantly linked with the survival outcome of ccRCC patients and the transcriptional level of CDH4 may serve as an effective diagnostic and prognostic biomarker for ccRCC patients [21]. The gene discussed is CDH4; the disease is nonpapillary renal cell carcinoma.